Protegrin-3

General Information


DRACP ID  DRACP03477

Peptide Name   Protegrin-3

Sequence  RGGGLCYCRRRFCVCVGR

Sequence Length  18

UniProt ID  P32196 

PubChem CID  Not available

Origin  Synthetic

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  2MZ6 

Predicted Structure  DRACP03477

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C84H141N33O20S4

Absent amino acids  ADEHIKMNPQSTW

Common amino acids  R

Mass  236490

Pl  9.72

Basic residues  5

Acidic residues  0

Hydrophobic residues  4

Net charge  5

Boman Index  -4988

Hydrophobicity  -2.22

Aliphatic Index  53.89

Half Life 
  Mammalian: 1.4 hour
  Yeast: 3 min
  E.coli: >10 hour

Extinction Coefficient cystines  1740

Absorbance 280nm  102.35

Polar residues  9

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25818457

Title  Characterization of cell selectivity, physiological stability and endotoxin neutralization capabilities of ?-helix-based peptide amphiphiles

Doi Not available

Year  2015

Literature 2

Pubmed ID 15629531

Title  Protegrin structure-activity relationships: using homology models of Synthetic peptide sequences to determine structural characteristics important for activity

Doi Not available

Year  2005

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  4756

DRACP is developed by Dr.Zheng's team.